FOXP3 and neoplasm: Lozano et al. found that a 15-mer synthetic peptide (P60) was able to bind to FOXP3, abrogate the FOXP3/AML1 interaction, and impede Treg cell activity, which caused significant anti-tumor activity both in vitro and in vivo.